DUBLIN, May 3, 2019 /PRNewswire/ -- The "Drafting and Negotiating Clinical Trial Agreements" conference has been added to ResearchAndMarkets.com's offering.
Clinical trial agreements are one of the most important agreements in the pharma industry as no research can start without the right agreement in place between sponsor and host organisation. They provide a contract which manages the relationship and responsibilities of both parties, and provide for the allocation of risk, obligations, the protection of academia, terms of collaboration, IP rights and much more.
This intensive one-day programme, delivered by experts in the field, will provide you with a full understanding of the importance of CTAs. It will describe how the regulatory environment affects them and explain the typical clauses which make up a CTA and what the key differences are between European and the US. By the end of this seminar you will be confident in spotting and addressing issues which arise when negotiating and drafting clinical trial agreements.
Who should attend?
- Contract managers
- Clinical contract specialists
- Clinical trial managers
- R&D staff
- Regulatory specialists
- Lawyers
- Legal executives
Agenda:
Overview of the legal/policy landscape as it affects the terms of CTAs
- What is a clinical trial?
- EU regulatory framework: What are the key regulatory considerations relevant to conducting a clinical trial?
- Introduction to the parties to the CTA and key roles and responsibilities
- Policy issues in public hospitals, e.g. UK NHS approval
- Other ethical/legal issues
- Standard contracts, e.g. NHS standard CTA
- Implications of Brexit
CASE STUDY
Negotiating and drafting CTAs
- Overview of issues that frequently come up in the negotiation/drafting of CTAs
- Introduction to case study
- Discussion of case study
- Definitions
- Intellectual property and publication provisions
- Use of data generated during the trial
- Data protection, medical records, freedom of information, etc
CASE STUDY
Negotiating and drafting CTAs - Continued discussion of case study:
- Manufacture of the investigational medicinal product
- Warranties and indemnities
- Liabilities and insurance requirements
- Termination and its consequences
Additional considerations
- Introduction to differences between US, UK and Continental European legal systems and how they may affect contract drafting
- Unlicensed product vs off-label use
- First-in-man studies
- Investigator initiated studies
- Compliance and anti-corruption issues
PRACTICAL EXERCISE - Negotiation
Speakers
Adela Williams
Adela Williams is Partner in the life sciences group at Arnold & Porter. She advises clients in relation to the regulation of medicinal products in the UK and at the EU level. She also regularly advises on clinical trial issues and represents clients in product liability litigation arising from use of medicines in the research context.
Jacqueline Mulryne
Jackie Mulryne is Counsel in the life sciences group at Arnold & Porter. She has a broad practice providing regulatory compliance and public policy advice, and has extensive experience advising commercial clients on clinical trial agreements, both within and outside the NHS, and variations across the EU.
Ewan Townsend
Ewan Townsend is Counsel in Arnold & Porter's London office and assists clients in the life sciences sector on regulatory and commercial matters. He has experience with a broad range of regulatory issues that arise throughout the medicinal product and medical device life cycle, including research and development, clinical trials, marketing authorisations, manufacturing, distribution, advertising, pricing and reimbursement. Ewan's work also includes drafting and negotiating commercial agreements for his life sciences clients, such as licence agreements, manufacturing, distribution and supply agreements, clinical trial agreements and service agreements, and advising on the intellectual property and regulatory issues that arise in the context of those transactions.
For more information about this conference visit https://www.researchandmarkets.com/r/gzqniw
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
http://www.researchandmarkets.com
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article